Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-02

Clinical Trial Update: Study of Potential for Interaction of Fluconazole With F901318 [Phase 1]

View source ↗

Summary

A Phase 1 study completed to assess potential pharmacokinetic interaction between fluconazole and F901318 in invasive aspergillosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • F901318
  • Fluconazole (Fluconazole)

Snippet

Sponsor: F2G Biotech GmbH | Conditions: Invasive Aspergillosis | Phase 1 | Status: COMPLETED